Vical to Provide Company Update at BIO Investor Forum Conference

[End Subhead]
[Start Distributor]
GlobeNewswire 13-Oct-2017 4:05 PM
[End Distributor]
SAN DIEGO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 11:30 a.m. PT on Wednesday, October 18, at the BIO Investor Forum Conference (San Francisco October 17-18). A webcast of the companys presentation will be available live through the Events & Presentations page in the Investors section of the Vical website at
About Vical Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at
Contact: Tony Ramos(858)

Wait, Before You Leave...